QualityStocksNewsBreaks Archives - Page 254 of 1428

TuesdayAug 08, 2023 10:21 am

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Enters Strategic MSA

GEMXX (OTC: GEMZ), a leader in the Ammolite Gems mine-to-market segment, recently announced its entry into an Ammolite Master Supply Agreement (“MSA”) with Canadian Ammolite Gems by Kenneth Bradley. Kenneth Bradley, who hosts multiple live, on-air events annually featuring unique Ammolite jewelry designs, is one of the world’s most recognized Ammolite experts and is a Canadian influencer with a global following that continues to grow. “This Ammolite supply agreement is a fundamental step in the company’s expansion plans,” Jay Maull, CEO and founder of GEMXX, said in the news release. “GEMXX and Kenneth Bradley share a goal of creating awareness…

TuesdayAug 08, 2023 9:30 am

QualityStocksNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Releases Q2 2023 Financial Report, Corporate Update

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has released its financial and corporate report for the second quarter, the period ended June 30, 2023. Financial highlights of the report include a 9% increase in total revenue with revenue coming in at $2.8 million; gross margins of 16%, a company record; and product revenue reaching $2.8 million, a 92% increase. Second quarter 2023 GAAP net loss was $14.2 million, with non-GAAP net loss reaching $11.8 million and adjusted EBITDA totaling $(12.6) million. Business highlights for the quarter included record shipments of lidar units in both the…

MondayAug 07, 2023 2:57 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Davidson Technologies Showcase National Defense Solutions at Space and Missile Defense Symposium

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is collaborating with Davidson Technologies Inc. to create innovative new solutions to complex problems in the defense and aerospace sectors. Davidson Technologies is a technology services company that provides innovative engineering, technical and management solutions for the Department of Defense, aerospace and commercial customers. The two companies are participating in this week’s Space and Missile Defense Symposium. According to the announcement, D-Wave and Davidson Technologies have built two new applications. The interceptor assignment app is designed to mitigate potential attacks by evaluating a multitude of complex…

MondayAug 07, 2023 2:15 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Helping to Efficiently Move Commerce with Fr8App Solution

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a supply chain innovator, recently welcomed an extensive new pool of truck drivers working within the United States-Mexico-Canada Agreement (“USMCA”) trade area, expanding the reach of its platform and increasing the ability of commercial freight transportation networks to manage shipping loads of all sizes. “Fr8Tech recently announced completion of its collaboration with automated booking solutions platform Trucker Tools, integrating Trucker Tools’ extensive network of over 315,000 carriers across the United States with Fr8Tech’s load-matching solution Fr8App,” a recent article reads. “Fr8App streamlines the process of connecting shippers with carriers within the USMCA (formerly ‘NAFTA’), both…

MondayAug 07, 2023 1:03 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Distinguished with Unique Capabilities

CNS Pharmaceuticals (NASDAQ: CNSP), a Texas-based cancer drug innovator, is focused on advancing its potentially pivotal clinical trial to track the effectiveness of drug candidate Berubicin in treating glioblastoma (“GBM”) brain cancers. Berubicin has already produced one patient with over 15 years of GBM survival. “Berubicin distinguishes itself by being virtually unique in its status as a cancer-fighting anthracycline that crosses the blood-brain barrier to attack central nervous system tumors directly. Berubicin also distinguished itself by presenting statistically significant improvement in nearly half of the two dozen patients evaluated in a phase I trial in 2006, including one patient whose…

MondayAug 07, 2023 12:44 pm

QualityStocksNewsBreaks – FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Eyes 2024 Delivery of FP300 Commercial Systems, Answering Larger-Scale Need with FP1500

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is a green technology company committed to developing commercially viable and sustainable onsite containerized green ammonia production systems. In early May, the company announced that it had begun running the final commissioning of its first farm-ready demonstration system, a production unit capable of producing 300 kg per day of green anhydrous ammonia or a little over 100 metric tons per year. Aptly named the FP300 model, the system will be heavily monitored for a full year on the 11,000-acre crop farm of Tracy and Curtis Hiebert, with the results shaping future systems being built concurrently…

MondayAug 07, 2023 11:13 am

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Issues Corporate Update, Eyes Expansion Plans

GEMXX (OTC: GEMZ), a leader in the Ammolite Gems mine-to-market segment, recently provided a corporate update and highlighted the company’s achievements and its accomplishment of significant milestones. The company controls each stage of its production, which includes gold mining, gemstone production, jewelry manufacturing, and global distribution. Its management team consists of the industry’s leading experts with a combined 160 years of gold, gemstone and jewelry business experience. “We are tremendously pleased with the development of the company over the past several months, and we are extremely excited for the anticipated growth,” Jay Maull, GEMXX CEO, said in the news release.…

FridayAug 04, 2023 3:55 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) Demo Plant Represents Unique Technological Advantage

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is steadily and quickly developing its infrastructure for North America-based rare earth element (“REE”) processing, strengthening its competitive position and ability to disrupt the People’s Republic of China’s control of the North American REE supply chain. “Ucore began demonstrating the performance of its proprietary RapidSX(TM) solvent extraction process during the spring at an Ontario, Canada facility, and on June 29 the company announced acquisition of a third REE feedstock for the demonstration plant, establishing it as a first-of-a-kind facility in North America… The Canadian demonstration plant is designed to show how RapidSX can…

FridayAug 04, 2023 3:43 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Eyes Remarkable Opportunity to Outline Two World-Class Deposits

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company, remains on track to publish its inaugural NI 43-101 compliant mineral resource estimate focused around the Santa Barbara High-Grade Zone at its Iska Iska site. Simultaneously, the company is looking to continue its ongoing drilling and geophysical surveys in the southernmost extremes of the Iska Iska site as well as within the Casiterita property to the southwest. “A positive finding, coupled with initial successes within the site’s Santa Barbara region, could translate into a scenario, which as Eloro’s Executive Vice President of Exploration Bill Pearson puts it,…

FridayAug 04, 2023 3:32 pm

QualityStocksNewsBreaks – Genprex Inc.’s (NASDAQ: GNPX) Third Fast Track Designation Validates REQORSA(R)’s Potential

Genprex (NASDAQ: GNPX), a gene therapy company, recently received U.S. FDA Fast Track Designation (“FTD”) for its lead product candidate, REQORSA(R) immunogene therapy, in combination with Tecentriq(R), a cancer immunotherapy treatment developed and sold by Genentech, Inc., in patients with extensive-stage small cell lung cancer (“ES-SCLC”) who did not develop tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. “The FTD is for the company’s Acclaim-3 patient population, and Genprex expects to initiate its Acclaim-3 clinical trial by enrolling the first patient in the third quarter of 2023… The company previously received two other FTDs. In 2020, Genprex…

Site Search

Company Search

Category: QualityStocksNewsBreaks